Suppr超能文献

黏合剂在湿法制粒中的效果:使用不同可压性的模型配方进行比较。

Effectiveness of binders in wet granulation: a comparison using model formulations of different tabletability.

机构信息

Novartis, Inc., Building K-407.2.65, CH-4002, Basel, Switzerland.

出版信息

Drug Dev Ind Pharm. 1997;23(8):791-808. doi: 10.3109/03639049709150550.

Abstract

Abstract Based on an analysis of model granulates and tablets, a comparison was made of the effectiveness of the binders PVP K30 PH, Cellulose HP-M 603, Lycatab DSH, Lycatab PGS, and L-HPC (type LH 11). A high shear mixer was used to prepare two model granulates (placebo and paracetamol) under processing conditions which were, as far as possible, comparable. The binders were added as proportions of 2%, 6%, and 10%. Water was used as the granulating liquid. The properties of the placebo granulates (particle size distribution, bulk and tapped density, granule strength, flow properties), and those of the tablets (crushing strength, friability) prepared from these granulates under different compaction forces, were generally good. However, with PVP, Cellulose HP-M603, and Lycatab, the disintegration time of the tablets did not meet pharmacopoeial requirements even though a "disintegrant" was used in the "outer phase." The paracetamol formulations were prime examples of high-dose drug substances with particularly poor granulating and tabletting properties, well suited to reveal differences between the binders. The paracetamol granulates were of higher friability and less flowability than the placebo granulates. The tablets tended to cap, friability was (with few exceptions) high, and disintegration times were long. In the preparation of model tablets containing paracetamol, PVP K30 PH (6%). and Cellulose HP-M 603 (6%) turn out to be the binders of choice with respect to crushing strength, but the disintegration times are too long. Lycatab PGS, Lycatab DSH, and L-HPC-LH 11 could not be used to produce paracetamol tablets that met the requirements.

摘要

摘要 通过对模型颗粒和片剂的分析,比较了 PVP K30 PH、纤维素 HP-M 603、Lycatab DSH、Lycatab PGS 和 L-HPC(LH 11 型)等黏合剂的有效性。在尽可能可比的加工条件下,使用高剪切混合机制备两种模型颗粒(安慰剂和扑热息痛)。将黏合剂以 2%、6%和 10%的比例添加。水用作造粒液。这些颗粒制成的安慰剂颗粒的性质(粒度分布、堆积和振实密度、颗粒强度、流动特性)以及在不同压缩力下由这些颗粒制成的片剂的性质(压碎强度、脆性)通常都很好。然而,即使在外相中使用了“崩解剂”,使用 PVP、纤维素 HP-M603 和 Lycatab 时,片剂的崩解时间仍不符合药典要求。扑热息痛配方是高剂量药物制剂的典型代表,其制粒和压片性能特别差,非常适合揭示黏合剂之间的差异。扑热息痛颗粒的脆性和流动性均低于安慰剂颗粒。片剂倾向于帽顶,脆性(除少数例外)较高,崩解时间较长。在制备含有扑热息痛的模型片剂时,PVP K30 PH(6%)和纤维素 HP-M 603(6%)在压碎强度方面是首选的黏合剂,但崩解时间过长。Lycatab PGS、Lycatab DSH 和 L-HPC-LH 11 不能用于生产符合要求的扑热息痛片剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验